The medical cannabis market has grown significantly in recent years. In Germany, the quantity of imported cannabis products has increased dramatically. In comparison to only 1.2 tons in 2017, German medical cannabis distributors imported about 3.13 metric tons of cannabis flowers for direct medical care of patients in 2018, while around 120 kg have been re-exported. In 2019, this amount doubled to around 6.7 tons.
An Outline of the German Medical Cannabis Market
BackgroundThe medical cannabis market has grown significantly in recent years. In Germany, the quantity of imported cannabis products has increased dramatically. In comparison to only 1.2 tons in 2017, German medical cannabis distributors imported about 3.13 metric tons of cannabis flowers for direct medical care of patients in 2018, while around 120 kg have been re-exported. In 2019, this amount doubled to around 6.7 tons.
BioAscent strengthens US business
AppointmentsNick Moore now supports Scottish BioAscent Discovery Ltd. in further developing its business in North America.
BioGeneration Ventures closes BGV IV Fund at €105m
Latest NewsBioGeneration Ventures has closed its fourth VC fund for European start-ups (BGV IV) at €105m.
LSP leads €11m Series A round in OneProject
Latest NewsOneProjects Ltd, an Irish-German cardiac imaging specialist, has closed an €11m Series A financing led by Amsterdam-headquartered life sciences investor LSP.
Illumina and Epidarex Capital invest in post-Brexit UK
Latest NewsIllumina has opened its first accelerator outside the US in Cambridge to fund genomics start-ups. Meanwhile, Epidarex Capital has raised £102m for UK biotechs.
Biognosys appoints new Chairman
AppointmentsSchlieren-based proteomics specialist Biognosys AG announces the appointment of Dr Patrick Vink as Chairman of the board.
Novel adjuvant teases T cells to respond to HCV
Latest NewsResearchers from Italy, Denmark and the UK have devised a new vaccination strategy to tackle hepatitis C and boosting the required strong T cell response.
First drug found to reduce COVID-19-mortality
Latest NewsA clinical trial has identified the first immuno-modulatory drug to significantly reduce COVID-19 mortality in ventilated patients.
Germany puts €300m in CureVac AG for COVID-19 vaccine
Latest NewsIn the race aimed at securing access to COVID-19 vaccines, Germany has acquired a minority stake in the local mRNA vaccine producer Curevac AG.
New CEO at Ipsen
AppointmentsDavid Loew, formerly executive vice president of Sanofi Pasteur, was appointed as CEO of French Ipsen Pharma SA at the beginning of July.